Certara To Buy Compliance Software Provider For $310; Q2 Earnings Beat Expectations, Raises FY21 Guidance
See more from Benzinga
Sierra Oncology Bets 6M On AstraZeneca's BET Inhibitor For Myelofibrosis
Quidel Stock Falls As Q2 Earnings Miss Street Estimates On Lower COVID-19, Influenza Product Sales
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.